# emtricitabine, rilpivirine and tenofovir disoproxil fumarate

NDC: 42385-801
Generic name: emtricitabine, rilpivirine and tenofovir disoproxil fumarate
Labeler / Manufacturer: Laurus Labs Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260305

FDA application: ANDA220232

## Active ingredients

- EMTRICITABINE: 200 mg/1
- RILPIVIRINE HYDROCHLORIDE: 25 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42385-801"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42385-801
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7193c90e-456c-4cfb-8181-65a1618dae51